![]() Incanthera Incanthera is a company that engages in the development of novel treatments for solid tumors (cancers). | ![]() G1 Therapeutics G1 Therapeutics is a biopharmaceutical company focused on the development and commercialization of small molecule therapeutics for the treatment of patients with cancer. | ![]() Alpine Immune Sciences Alpine Immune Sciences is a biotechnology company that develops protein-based immunotherapies. | ||
Founding Date | Founding Date 2010 | Founding Date 2008 | Founding Date 2015 | Founding Date 2009 |
Type | Type Private | Type Public | Type Subsidiary | Type Private |
Tags | ||||
Locations | Locations Manchester, GB HQ Bradford, GB | Locations Durham, US HQ | Locations Seattle, US HQ | Locations Suzhou Shi, CN HQ |
Employees | Employees N/A | Employees 17015% increase | Employees 484% decrease | Employees 42 |
Financial | ||||
Revenue (est.) | Revenue (est.) N/A | Revenue (est.) $82.5m (FY, 2023) | Revenue (est.) $58.9m (FY, 2023) | Revenue (est.) N/A |
Net income | Net income N/A | Net income ($48m) (FY, 2023) | Net income ($32.2m) (FY, 2023) | Net income N/A |
Funding | ||||
Latest funding round | Latest funding round $ 1.1m (over 12 years ago) | Latest funding round N/A | Latest funding round N/A | Latest funding round $ 60m (about 7 years ago) |
Total funding raised | Total funding raised $ 1.1m | Total funding raised $ 289.6m | Total funding raised $ 49.3m | Total funding raised $ 160m |

G1 Therapeutics is a biopharmaceutical company focused on the development and commercialization of small molecule therapeutics for the treatment of patients with cancer.
View company
Alpine Immune Sciences is a biotechnology company that develops protein-based immunotherapies.
View company
Alphamab Oncology is a clinical-stage biopharmaceutical company.
View company